ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,314.13
0.11%
US Tech 100
18,204.00
0.04%
다우존스 지수
39,830.32
0.06%
Bitcoin
69,676.89
-2.48%
Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Angion Biomedica Corporation (ANGN)

  7. Angion Biomedica Corporation (ANGN) 뉴스

ANGN

Angion Biomedica (ANGN)

Angion Biomedica Corporation
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:ANGN
일자시간출처헤드라인심볼기업
2024/04/2920:00Edgar (US Regulatory)Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]NASDAQ:ANGNAngion Biomedica Corporation
2024/04/0605:33Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANGNAngion Biomedica Corporation
2024/03/3004:28Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:ANGNAngion Biomedica Corporation
2024/03/3004:26Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:ANGNAngion Biomedica Corporation
2024/03/3002:58Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:ANGNAngion Biomedica Corporation
2024/03/2921:35Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANGNAngion Biomedica Corporation
2024/03/2105:37Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:ANGNAngion Biomedica Corporation
2024/03/2105:28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANGNAngion Biomedica Corporation
2024/03/1821:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANGNAngion Biomedica Corporation
2024/02/0520:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANGNAngion Biomedica Corporation
2024/02/0520:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANGNAngion Biomedica Corporation
2024/02/0520:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANGNAngion Biomedica Corporation
2024/02/0520:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANGNAngion Biomedica Corporation
2024/02/0222:51Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANGNAngion Biomedica Corporation
2024/01/1722:35Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANGNAngion Biomedica Corporation
2024/01/1621:59Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANGNAngion Biomedica Corporation
2024/01/0922:11Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANGNAngion Biomedica Corporation
2024/01/0606:05Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:ANGNAngion Biomedica Corporation
2023/12/3007:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANGNAngion Biomedica Corporation
2023/12/3007:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANGNAngion Biomedica Corporation
2023/12/2706:29Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANGNAngion Biomedica Corporation
2023/12/2706:25Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:ANGNAngion Biomedica Corporation
2023/12/2223:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANGNAngion Biomedica Corporation
2023/11/1322:45Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ANGNAngion Biomedica Corporation
2023/11/1006:41Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANGNAngion Biomedica Corporation
2023/11/0406:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANGNAngion Biomedica Corporation
2023/10/2020:58Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANGNAngion Biomedica Corporation
2023/10/1220:59Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANGNAngion Biomedica Corporation
2023/09/0721:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANGNAngion Biomedica Corporation
2023/08/3105:33Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANGNAngion Biomedica Corporation
 검색 관련기사 보기:NASDAQ:ANGN

최근 히스토리

NYSE
AXP
American Express
PM
XAUUSD
Gold vs US Dollar
USOTC
BNPQY
BNP Paribas (QX)
NASDAQ
MSFT
Microsoft
NASDAQ
NVDA
NVIDIA
NYSE
BAC
Bank of America
COIN
ETHUSD
Ethereum
NYSE
MRK
Merck
CCOM
US500
US 500
USOTC
RHHBY
Roche (QX)
NASDAQ
GOOGL
Alphabet
NYSE
MCD
McDonalds
COIN
BTCUSD
Bitcoin
AMEX
XLF
Financial Select Sector
USOTC
ADDYY
Adidas (QX)
Delayed Upgrade Clock
ADVFN Logo

대한민국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유